Aarey Drugs & Pharmaceuticals

AAREYDRUGS

SectorHealthcare

Insights Financials Evidence

‌
‌
‌
‌
‌
‌
‌
‌

‌

‌
‌

‌
‌
‌

‌
‌

‌

‌
‌
‌
‌
‌
‌
‌

‌
‌
‌
‌
‌
‌

Aarey Drugs & Pharmaceuticals Stock Price - ₹112.91 | Healthcare | askfuzz

Aarey Drugs & Pharmaceuticals

AAREYDRUGS

SectorHealthcare

Insights Financials Evidence

‌
‌
‌
‌
‌
‌
‌
‌

Announcements

Exchange filings, newest first

5 Oct
3 Oct
8 Sept

Documents by quarter

Results, presentation and transcript tracked for every quarter

Quarterly Result Q1 FY2026-27

3 pages

Annual Reports

Management Discussion, Balance Sheet and more

Annual Reports 2025-26

12 pages

Annual Reports 2024-25

124 pages

Annual Reports 2023-24

116 pages

Other Filings

KMP changes, governance and LODR disclosures

DateFilingCategory

30 Sept 2026Aarey Drugs & Pharmaceuticals Ltd outcome of 36th AGM held on 30 Sep 2026, adopting FY26 financials and re-appointing Mrs. Bina GhataliaRecord Date

30 Sept 2026Aarey Drugs & Pharmaceuticals Ltd board approves allotment of 11,50,000 equity shares on 30 Sep 2026 upon conversion of warrantsCapital Raise

11 Sept 2026Aarey Drugs & Pharmaceuticals Ltd disclosure of letters sent to shareholders with web link to access Integrated Annual Report for FY26Record Date

8 Sept 2026Aarey Drugs & Pharmaceuticals Ltd record date for 36th Annual General Meeting from 24 Sep 2026 to 30 Sep 2026Record Date

8 Sept 2026Aarey Drugs & Pharmaceuticals Ltd AGM scheduled on 30 Sep 2026Record Date

5 Sept 2026Aarey Drugs & Pharmaceuticals Ltd outcome of board meeting on 5 Sep 2026 approving Annual Report and 36th AGM noticeRecord Date

30 May 2026Aarey Drugs & Pharmaceuticals Limited Annual Secretarial Compliance Report for FY26 under Regulation 24A scheduled on 30 May 2026Audit Reports